USPTO serial 87734294
WUXIBODY
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 21, 2021
- Examiner
- GALBO, AMANDA
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with WUXIBODY?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*
Plus Government fees of $325
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
WUXI BIOLOGICS IRELAND LIMITED
DUNDALK, COUNTY LOUTH, IE
WuXi AppTec Biopharmaceuticals Co., Ltd.
Mashan, WuXi,, CN
Other trademarks owned by WuXi AppTec Biopharmaceuticals Co., Ltd.
WuXi AppTec Biopharmaceuticals Co., Ltd.
Mashan, WuXi,, CN
Other trademarks owned by WuXi AppTec Biopharmaceuticals Co., Ltd.
WuXi AppTec Biopharmaceuticals Co., Ltd.
Mashan, WuXi,, CN
Other trademarks owned by WuXi AppTec Biopharmaceuticals Co., Ltd.
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Michael T. Smith
Michael T. Smith Birch Stewart Kolasch & Birch, LLP8110 Gatehouse Road, Suite 100 EastFalls Church, VA 22042UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cancer, autoimmune disease, coagulation disorder, infectious disease; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Pharmaceutical preparations, namely, therapeutic antibody drug containing a bispecific antibody formulation which can be used to treat cancers, inflammatory diseases, autoimmune diseases, infectious diseases, and coagulation disorders; Biological preparations for the treatment of cancer, autoimmune disease, coagulation disorder, infectious disease; Disinfectants for hygiene purposes; Chewing gum for medical purposes; Nutritional supplements | ACTIVE | May 14, 2021 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by WUXI BIOLOGICS IRELAND LIMITED
- Other trademarks owned by WuXi AppTec Biopharmaceuticals Co., Ltd.
- Other trademarks owned by WuXi AppTec Biopharmaceuticals Co., Ltd.
- Other trademarks owned by WuXi AppTec Biopharmaceuticals Co., Ltd.
- Other trademarks in Class 005
- Similar marks named WUXIBODY
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 1, 2022 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| May 25, 2022 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Dec 21, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 19, 2021 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Nov 18, 2021 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Nov 18, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 18, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 18, 2021 | ALIE | ASSIGNED TO LIE | — |
| Nov 15, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 2, 2021 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 2, 2021 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 2, 2021 | CNRT | SU - NON-FINAL ACTION - WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 25, 2021 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Jun 21, 2021 | IUAF | USE AMENDMENT FILED | — |
| Jun 21, 2021 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Apr 23, 2021 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Apr 23, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 23, 2021 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Apr 23, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 23, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 23, 2021 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jan 12, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 11, 2021 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Jan 7, 2021 | EXT5 | SOU EXTENSION 5 FILED | — |
| Jan 7, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 23, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 21, 2020 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Jul 21, 2020 | EXT4 | SOU EXTENSION 4 FILED | — |
| Jul 21, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 22, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 20, 2020 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Jan 20, 2020 | EXT3 | SOU EXTENSION 3 FILED | — |
| Jan 20, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 13, 2019 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 11, 2019 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Jul 11, 2019 | EXT2 | SOU EXTENSION 2 FILED | — |
| Jul 11, 2019 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 20, 2019 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Mar 20, 2019 | NOAC | CORRECTED NOA E-MAILED | — |
| Mar 19, 2019 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Mar 19, 2019 | DPCC | DIVISIONAL PROCESSING COMPLETE | — |
| Mar 1, 2019 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Feb 5, 2019 | EPPA | TEAS POST PUBLICATION AMENDMENT RECEIVED | — |
| Jan 21, 2019 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jan 21, 2019 | ERTD | TEAS REQUEST TO DIVIDE RECEIVED | — |
| Jan 21, 2019 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 24, 2018 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| May 29, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 29, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 9, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 25, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 24, 2018 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 24, 2018 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Apr 24, 2018 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Apr 24, 2018 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 11, 2018 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 11, 2018 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Apr 11, 2018 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Apr 11, 2018 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 6, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 21, 2018 | DRRR | DIVISIONAL REQUEST RECEIVED | — |
| Jan 12, 2018 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Jan 11, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 29, 2017 | NWAP | NEW APPLICATION ENTERED | — |